H5N1 News and Research

Latest H5N1 News and Research

Voluntary action by two research teams to halt work on H5N1 lauded

A Georgetown University Medical Center professor says the voluntary action taken by two research teams to temporarily halt work involving the highly pathogenic avian influenza H5N1 is "laudable."

24 Jan 2012

Settling controversy surrounding bird flu research will not be easy

The WHO is expected to hold a meeting in February to discuss controversy over recent research on the H5N1 bird flu virus, after the U.S. National Scientific Advisory Board for Biosecurity (NSABB) in December advised the journals Science and Nature to withhold publishing two teams' research on the virus for fear the information could "fall into the wrong hands," a commentary in the Economist's "Babbage" blog states.

24 Jan 2012

Scientists halt bird flu research for 60 days amid safety concerns

The head of the NIH National Institute of Allergy and Infectious Diseases (NIAID), which funded "two projects that created a highly pathogenic [H5N1] flu virus mutation, has welcomed a two-month moratorium on further research while defending the value and safety of the experiments," the Financial Times reports.

24 Jan 2012

Debate over publication of bird flu studies continues in journal opinion pieces

Ron Fouchier of Erasmus Medical Center in the Netherlands -- lead researcher of one of two teams that last year reported study results "that showed how the H5N1 [bird flu] virus can be transmitted through airborne droplets between ferrets, a model for studying influenza in humans."

21 Jan 2012

Georgetown professors explore balance of national security and scientific freedom

The U.S. government's request that the journals Science and Nature withhold scientific information related to the genetically modified H5N1 virus because of biosecurity concerns does not violate the First Amendment, say two Georgetown University professors. They caution, however, that a fair, transparent process undertaken by research organizations is preferable to governmental constraints on disseminating scientific information.

19 Jan 2012

Risks of modifying flu strains to become highly transmissible in humans outweigh benefits

In this Journal Sentinel Online opinion piece, Thomas Inglesby, chief executive officer and director of the Center for Biosecurity of UPMC in Baltimore; Anita Cicero, chief operating officer and deputy director of the center; and D.A. Henderson, a distinguished scholar at the center, comment on a recent announcement by scientists that they have genetically modified a strain of H5N1 bird flu that is "capable of spreading through the air between ferrets that were physically separated from each other," indicating "it would be readily transmissible by air between humans."

19 Jan 2012

NIH official discusses reaction to bird flu studies, development of publishing mechanism in Nature interview

Nature interviews Amy Patterson, director of the National Institutes of Health (NIH) Office of Science Policy, which administers the National Science Advisory Board for Biosecurity (NSABB), about the board's decision in December to advise against full publication of "two papers on avian flu (H5N1) that could pose a biosecurity risk if published in their entirety."

13 Jan 2012

Restricting publication of H5N1 research 'more perilous' than threat of biological warfare

In this Reuters opinion piece, New York-based writer Peter Christian Hall responds to "the U.S. government's move to restrict publication of vital research into H5N1 avian flu," writing, "This unprecedented interference in the field of biology could hinder research and hamper responsiveness in distant lands plagued by H5N1," yet "no one seems to be challenging a key assumption -- that H5N1 could make a useful weapon. It wouldn't."

11 Jan 2012

Colby's JVRS-100 enhances immunogenicity, cross-protective efficacy of H5N1 influenza vaccine

Colby Pharmaceutical Company (CPC) today announced publication of new results showing that a single dose of JVRS-100 adjuvanted H5N1 influenza vaccine enhanced-immune responses, -dose sparing, and -cross-clade influenza virus protection.

9 Jan 2012

WHO confirms bird flu cases in Egypt, China

The WHO on Thursday "announced the deaths of two men from H5N1 avian influenza, one from Egypt and another from China whose death was reported earlier in the media," CIDRAP News reports. Both men are suspected to have contracted the virus from avian sources, although an investigation into the man from China's exposure to the virus is ongoing, according to news service.

7 Jan 2012

Tetragenetics reports results from G-SOME H5N1 vaccine preclinical study

Tetragenetics Inc., a biotechnology company focused on the development of recombinant vaccines, today reported preclinical study results showing that an investigational nanoparticle-based influenza vaccine protects against a highly pathogenic H5N1 avian influenza strain.

6 Jan 2012

WHO issues warning about risks of research on human engineered bird flu

"The World Health Organization issued a stern warning on Friday to scientists who have engineered a highly pathogenic form of the deadly H5N1 bird flu virus, saying their work carries significant risks and must be tightly controlled," Reuters reports.

4 Jan 2012

Bird flu updates

The latest bird flu virus that killed a 39-year-old bus driver in the southern Chinese city of Shenzhen over the weekend is not yet transmissible between humans, Chinese health authorities said. The man, who lived in Shenzhen just across the border from Hong Kong, died from multi-organ failure on Saturday, a week after being admitted to hospital with a fever brought on by the virus, state media reported.

3 Jan 2012

Chinese man dies of bird flu

A 39 year old Chinese bus driver tested positive for the H5N1 bird flu virus and died Saturday in a city bordering Hong Kong. According to health officials this is the country’s first reported case of the disease in humans in 18 months.

2 Jan 2012

CEL-SCI to expand Multikine Phase III trial in head and neck cancer

CEL-SCI Corporation is in the process of expanding its Phase III clinical trial of the investigational therapy Multikine (Leukocyte Interleukin, Injection) to 4 additional European countries - Spain, Czech Republic, Slovakia and Croatia.

27 Dec 2011

CEL-SCI reports net loss of $26.8M for fiscal year ended September 30, 2011

CEL-SCI Corporation reported financial results today for the fiscal year ended September 30, 2011.

26 Dec 2011

Federal officials seek to keep details on bird flu study secret

A federal board has asked two scientific journals to restrict access to details of a genetic study of the bird flu in which researchers altered the virus to be more easily transmittable between humans.

23 Dec 2011

Longer looks: Manufacturing killer flu; The ironies of the individual mandate; When the elderly refuse help

In experiments conducted at the University of Wisconsin in Madison and Erasmus University in Rotterdam, the Netherlands, researchers engineered a strain of H5N1. … The next logical step would be for the researchers to publish studies in major scientific journals, describing the newly created flu, including its genetic makeup.

23 Dec 2011

First Edition: December 22, 2011

Today's early morning highlights from the major news organizations, including articles on the Capitol Hill stalemate that threatens to cut Medicare payments to doctors and government efforts to keep details of a research experiment on bird flu secret.

22 Dec 2011

U.S. Science Advisory Board asks Science, Nature to omit data from bird flu studies amid security concerns

The U.S. National Science Advisory Board for Biosecurity on "Tuesday asked two scientific journals to leave out data from research studies on a lab-made version of bird flu that could spread more easily to humans, fearing it could be used as a potential weapon," Reuters reports.

22 Dec 2011

H5N1 News and Research

Latest H5N1 News and Research

Voluntary action by two research teams to halt work on H5N1 lauded

Settling controversy surrounding bird flu research will not be easy

Scientists halt bird flu research for 60 days amid safety concerns

Debate over publication of bird flu studies continues in journal opinion pieces

Georgetown professors explore balance of national security and scientific freedom

Risks of modifying flu strains to become highly transmissible in humans outweigh benefits

NIH official discusses reaction to bird flu studies, development of publishing mechanism in Nature interview

Restricting publication of H5N1 research 'more perilous' than threat of biological warfare

Colby's JVRS-100 enhances immunogenicity, cross-protective efficacy of H5N1 influenza vaccine

WHO confirms bird flu cases in Egypt, China

Tetragenetics reports results from G-SOME H5N1 vaccine preclinical study

WHO issues warning about risks of research on human engineered bird flu

Bird flu updates

Chinese man dies of bird flu

CEL-SCI to expand Multikine Phase III trial in head and neck cancer

CEL-SCI reports net loss of $26.8M for fiscal year ended September 30, 2011

Federal officials seek to keep details on bird flu study secret

Longer looks: Manufacturing killer flu; The ironies of the individual mandate; When the elderly refuse help

First Edition: December 22, 2011

U.S. Science Advisory Board asks Science, Nature to omit data from bird flu studies amid security concerns

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

H5N1 News and Research

Latest H5N1 News and Research

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in